ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 890 filers reported holding ISHARES TR in Q4 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,766 | +12.4% | 644 | +16.7% | 0.00% | 0.0% |
| Q2 2023 | $70,093 | -1.7% | 552 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $71,308 | -8.4% | 552 | -6.9% | 0.00% | -20.0% |
| Q4 2022 | $77,865 | +27.6% | 593 | +11.9% | 0.01% | +25.0% |
| Q3 2022 | $61,000 | -58.8% | 530 | -57.2% | 0.00% | -42.9% |
| Q2 2022 | $148,000 | -5.7% | 1,239 | +2.2% | 0.01% | 0.0% |
| Q1 2022 | $157,000 | -51.7% | 1,212 | -43.2% | 0.01% | -41.7% |
| Q4 2021 | $325,000 | -14.5% | 2,133 | -10.9% | 0.01% | -20.0% |
| Q3 2021 | $380,000 | -5.5% | 2,394 | -1.9% | 0.02% | -6.2% |
| Q2 2021 | $402,000 | -4.1% | 2,441 | -10.0% | 0.02% | +33.3% |
| Q1 2021 | $419,000 | -14.0% | 2,711 | -36.6% | 0.01% | -40.0% |
| Q4 2020 | $487,000 | -61.5% | 4,279 | -54.8% | 0.02% | -69.7% |
| Q3 2020 | $1,264,000 | +317.2% | 9,471 | +321.9% | 0.07% | +288.2% |
| Q2 2020 | $303,000 | +35.3% | 2,245 | +9.0% | 0.02% | +13.3% |
| Q1 2020 | $224,000 | -10.0% | 2,059 | +0.5% | 0.02% | +15.4% |
| Q4 2019 | $249,000 | +40.7% | 2,048 | +14.9% | 0.01% | +18.2% |
| Q3 2019 | $177,000 | -69.8% | 1,782 | -66.9% | 0.01% | -69.4% |
| Q2 2019 | $587,000 | -1.5% | 5,385 | +1.0% | 0.04% | -7.7% |
| Q1 2019 | $596,000 | +26.8% | 5,333 | +7.5% | 0.04% | +11.4% |
| Q4 2018 | $470,000 | -8.0% | 4,959 | +18.1% | 0.04% | +2.9% |
| Q3 2018 | $511,000 | +14.3% | 4,198 | +3.1% | 0.03% | -2.9% |
| Q2 2018 | $447,000 | -21.2% | 4,070 | -23.4% | 0.04% | -30.0% |
| Q1 2018 | $567,000 | -8.7% | 5,315 | -8.7% | 0.05% | -9.1% |
| Q4 2017 | $621,000 | -71.2% | 5,819 | -10.5% | 0.06% | -74.3% |
| Q3 2017 | $2,159,000 | +12.4% | 6,499 | +4.9% | 0.21% | +8.6% |
| Q2 2017 | $1,921,000 | +6.9% | 6,197 | +3.4% | 0.20% | +5.3% |
| Q1 2017 | $1,797,000 | +350.4% | 5,991 | +297.8% | 0.19% | +252.8% |
| Q4 2016 | $399,000 | -10.1% | 1,506 | -2.0% | 0.05% | -11.7% |
| Q3 2016 | $444,000 | +21.0% | 1,537 | +9.8% | 0.06% | +13.2% |
| Q2 2016 | $367,000 | +3.4% | 1,400 | +5.7% | 0.05% | -1.9% |
| Q1 2016 | $355,000 | – | 1,325 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |